Rabeprazole Sodium Tablet, Delayed Release
Product Images NDC 60760-560
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Rabeprazole Sodium (NDC 60760-560). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by St. Mary's Medical Park Pharmacy, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Rabe-str2 (Rabe Str2)
Rabe-str3 (Rabe Str3)
This is a table showing heartburn scores for two groups of participants in a study. One group was given a placebo (n=58) and the other group was given 20mg of RAB (n=59). The heartburn scores are measured on a scale of 0 to 5, with 0 meaning no heartburn and 5 meaning very severe heartburn. The scores are recorded for study days 0, 7, 14, 21, and 28.*
Rabe-str4 (Rabe Str4)
This is a chart that compares the heartburn scores of people taking placebo versus those taking Rab20mg. The study includes 59 participants and measures heartburn severity on a scale of 0 to 4 with 0 being no heartburn and 4 being very severe heartburn. The chart shows that on average, the mean score for placebo is 1.22 and the mean score for Rab20mg is 0.85.*
Rab (Rabeprazole 60760 560 30)
This is the label of Rabegrazole Sodium, a medicine produced by Alkem Laboralores Lid in Mumbai, India. The medication comes in table form, with each package containing 30 Delayed-Release tablets. Each tablet is either 20mg or g8 2 mg. The lot number and expiration date are also provided. The tablets are Rx-only and must be stored at room temperature.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.